Skip to main content

Animations

MJFF Publications

5751 - 5775 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2012
  • 2009
  • 2020
  • 2005
  • 2008
  • 2025
  • 2025
  • 2011
  • 2015
  • 2024
  • 2025
  • 2003
  • 2008
  • 2011
  • 2015
  • 2023
  • 2020
  • 2019
  • 2025
  • 2018
  • 2018
  • 2018
  • 2017
  • 2013
  • Summary Details
    OPEN
    Title: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29184
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 325
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 527
  • Summary Details
    OPEN
    Title: The unfolded protein response is activated in the olfactory system in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-020-00986-7
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
    Journal Name: BMC Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/1471-2202-6-71
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor
    Journal Name: Molecular Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1124/mol.108.048884
    Citation Count: 149
  • Summary Details
    OPEN
    Title: EndoMAP.v1 charts the structural landscape of human early endosome complexes
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-025-09059-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
  • Summary Details
    OPEN
    Title: BAX inhibitor‐1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Stochastic electrotransport selectively enhances the transport of highly electromobile molecules
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1510133112
    Citation Count: 237
  • Summary Details
    OPEN
    Title: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adn6016
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Triglycerides are an important fuel reserve for synapse function in the brain
    Journal Name: Nature Metabolism
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s42255-025-01321-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Pitx3 is required for development of substantia nigra dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0230529100
    Citation Count: 382
  • Summary Details
    OPEN
    Title: JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05713.x
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Regulation of Physiologic Actions of LRRK2: Focus on Autophagy
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000332599
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci78421
    Best OA location URL: http://doi.org/10.1172/JCI78421
    Citation Count: 194
  • Summary Details
    RESTRICTED
    Title: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0073-1
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
    Journal Name: JMIR Research Protocols
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/71955
    Best OA location URL: https://doi.org/10.2196/71955
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Impact of motor fluctuations on real-life gait in Parkinson’s patients
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045
    Citation Count: 30
  • Summary Details
    RESTRICTED
    Title: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review
    Journal Name: Clinical Neuropharmacology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Heritability estimates of cortical anatomy: The influence and reliability of different estimation strategies
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.05.014
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0189161
    Citation Count: 162
  • Summary Details
    RESTRICTED
    Title: Announcing a New Continuing Medical Education Course
    Journal Name: Cognitive and Behavioral Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fb
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.